Lack of T-cell proliferative response to HIV-1 antigens after 1 year of highly active antiretroviral treatment in early HIV-1 disease. Immunology Study Group of Spanish EARTH-1 Study

Lancet. 1998 Oct 10;352(9135):1194-5. doi: 10.1016/s0140-6736(05)60532-6.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antiviral Agents / therapeutic use*
  • CD4-Positive T-Lymphocytes / drug effects*
  • Case-Control Studies
  • Cell Division / drug effects
  • HIV Infections / drug therapy*
  • HIV Infections / immunology*
  • HIV-1*
  • Humans
  • Treatment Outcome

Substances

  • Antiviral Agents